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IMRT is a technique that adds fluence modulation to beam 
shaping, which improves radiotherapy dose conformity 
around the tumour and spares surrounding normal structures. 
Treatment with IMRT is becoming more widely available for 
the treatment of lung cancer, despite the paucity of high 
level evidence supporting the routine use of this more 
resource intense and complex technique [Chan. J Thor Oncol 
2014]. It allows the treatment of patients with large volume 
disease, close to critical organs at risk with curative doses.  
Very few prospective trials have reported on the use of IMRT. 
RTOG 0617 was a 2 x 2 factorial design study, in which 
patients with stage III NSCLC were randomized to receive 
high dose (74 Gy in 37 fractions) or standard dose (60 Gy in 
30 fractions) RT concurrently with weekly 
paclitaxel/carboplatin with or without cetuximab [Bradley. 
Lancet Oncol 2015]. The radiotherapy technique (3D 
conformal RT vs IMRT) was a stratification factor. 
Disappointingly, there was a significant increase in the risk of 
death in the high-dose arms (median survival, 19.5 months vs 
28.7 months; p=0.0007), and a 37% increase in the risk of 
local failure in the high-dose arms (hazard ratio, 1.37; 
p=0.0319). It should be noted that just under half of the 
patients in this study were treated with IMRT (46.5%). 
Although patients were stratified by treatment delivery 
technique and the proportions of patients treated with IMRT 
were balanced between treatment groups (46.1% in 60 Gy 
arms and 47.1% in 74 Gy arms), the delivery of 74 Gy was 
probably challenging, particularly in patients treated without 
IMRT, given the gross tumour volume (GTV) (mean 124.7 in 60 
Gy arms and 128.5 cc in 74 Gy arms).  
A subsequent analysis on patient reported outcome 
demonstrated a significantly worse quality of life on the 74 
Gy arms at 3 months after treatment [Mosvas JAMA 1015]. 
Interestingly, despite minimal differences in clinician-
reported side-effects between treatment arms, the decline in 
quality of life was significantly reduced with the use of IMRT 
compared to 3DCRT suggesting that the use of improved 
radiotherapy treatment techniques may be beneficial. 
Furthermore, baseline QOL was an independent prognostic 
factor for survival. A further analysis of RTOG0617 compared 
the outcome of patients treated with 3D-conformal and 
intensity modulated radiotherapy [Chun. ASTRO 2015]. 
Survival was the same in both groups in spite of the larger 
proportion of patients with stage IIIb vs IIIa and larger 
Planning Target Volume in the IMRT cohort. Moreover the use 
of IMRT reduced severe pneumonitis, dose delivered to the 
heart and more patients received chemotherapy in the IMRT 
cohort. 
Population-based studies have not shown any significant 
difference in overall survival, toxicity or time spent 
hospitalized following treatment between 3DCRT and IMRT 
[Harris. Int J Radiat Oncol Biol Phys 2014; Chen. J Thorac 
Oncol 2014]. The need remains to develop clinical trials that 
will demonstrate the benefit of IMRT in terms of toxicity, 
local control, survival or quality of life.  
A number of clinical trials are currently recruiting patients. 
Some are evaluating personalized dose escalation based on 
dose delivered to organs at risk (NCT01836692, NCT01166204) 
and others an increase dose to selected parts within the 
tumour, defined by functional imaging (Dose Painting) 
(NCT01024829, NCT01507428).  
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In countries with active mammography screening programs, 
the majority of breast cancers are diagnosed at an early 
stage. Those patients are treated with breast conserving 
surgery followed by adjuvant radiotherapy, which is 
equivalent to mastectomy in term of survival. The objective 
of the radio-surgical association is hence primarily cosmetic. 
Since those patients have excellent outcomes, it is logical to 
minimise any detrimental effects of the treatment, in term 
of acute and delayed side effects.  
Intensity Modulated Radiation Therapy (IMRT) is a radiation 
technique where the photon beam intensity is modulated 
across multiple irradiation fields to achieve a pre-determined 
goal for the dose distribution, using try and error methods. 
The goal can be to improve the conformality of the dose 
distribution or, as it is often the case for the breast, its 
homogeneity.  
There are many cohort studies and randomised clinical trials 
reporting on the clinical benefit for BIMRT used to improve 
the dose distribution homogeneity in the breast. A 
multicentre randomised controlled trial from Canada has 
demonstrated a large and significant reduction of acute skin 
toxicity, notably the moist desquamation occurring on the 
infra-mammary fold. This benefit was not present for large 
breasted patients. Moist desquamation was significantly 
associated with a severe pain and a reduction of Health 
Related Quality of Life (HRQoL). There are several studies 
reporting significant associations between the occurrence of 
moist desquamation and delayed side effects like 
telangiectasia and induration. Several randomised trials have 
also evaluated the impact of BIMRT on long-term side effect, 
and two studies from the UK using hypofractionated regimen 
showed a small but significant improvement of the cosmetic 
outcome at 5 years. It is important to note that no cosmetic 
improvement was found at 8 years in the Canadian study 
using conventional fractionation of 50 Gy in 25 treatments. In 
the Cambridge and Canadian studies there was no impact of 
the radiation technique on the long-term HRQoL. In the 
Canadian study there was a highly significant correlation 
between the initial pain experience at time of radiotherapy 
and the occurrence of chronic pain and a reduction in HRQoL 
at 8 years. Also the occurrence of moist desquamation at the 
time of radiation treatment was significantly correlated with 
the occurrence of telangiectasia, fibrosis and a poorer 
cosmetic outcome on self-evaluation questionnaire. Those 
studies suggest a complex interplay between the breast 
volume, the dose-fractionation schedule and the radiation 
technique. More recently, a study from Ghent demonstrated 
that for large breasted patients hypofractionated prone 
BIMRT significantly reduces moist desquamation compared to 
hypofractionated supine BIMRT.  
In summary, there are solid evidences to suggest that BIMRT 
reduces the occurrence of acute skin toxicity, including moist 
desquamation and pain. For large breasted women, the use 
of a prone technique BIMRT appears to significantly reduce 
moist desquamation. In regards to long-term side effect it 
seems that BIMRT could improve the cosmetic outcome when 
using hypofractionation, but its role is less clear when using a 
standard dose-fractionation regimen. A painful experience of 
moist desquamation during the initial radiation treatment is 
significantly associated with chronic pain and poorer HRQoL. 
Since BIMRT is a technique relatively simple to implement at 
no cost, outside the USA, it should be used as standard for 
adjuvant breast radiotherapy. 
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Most image guidance strategies today aim at minimizing 
random and/or systematic geometrical uncertainties by 
offline or online correction protocols based on either 
ESTRO 35 2016                                                                                                                                                    S295 
______________________________________________________________________________________________________ 
surrogates or the actual tumor position. Corrections are 
usually limited to translations, and rotational errors, shape 
change and intra-fractional changes are not corrected for. 
For targets with a large day-to-day shape variation, or in case 
of multiple targets with differential motion, generous safety 
margins have to be used that partly undo the healthy tissue 
sparing properties of modern radiation techniques such as 
IMRT and VMAT. Adaptive radiotherapy (ART), e.g. with a 
Plan-of-the-Day (PotD) strategy has been proposed to 
overcome this problem. Guidelines for proper selection of 
patients that need a replanning (e.g. lung, rectum), or 
implementation of a more labour-intensive PotDworkflow for 
groups of patients (e.g. cervix, bladder) have been major 
research topics in recent years.  
In this presentation, an overview will be given of current 
clinical implementations of PotD strategies in literature. The 
library-based PotD procedure as implemented at Erasmus MC 
for cervical cancer patients will be discussed in more detail. 
For these patients, a plan library contains 2 or 3 VMAT plans 
adequate for target shapes and positions corresponding to 
smaller and larger bladder volumes. Every treatment day, the 
best fitting plan is selected based on an in-room acquired 
cone beam CT scan, showing internal anatomy and markers 
implanted around the primary tumor. The recent PotD 
implementation in our record & verify system has pathed the 
way for a more wide-spread application of safe and efficient 
delivery of library-based PotD strategies, and for more 
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The clinical implementation of magnetic resonance image-
guided radiation therapy (MR-IGRT) has enabled the daily 
visualization of internal soft-tissue anatomy with the patient 
in the treatment position. The information provided by the 
daily MR, which may not be available in some other online 
imaging modalities such as cone-beam CT, has allowed us to 
evaluate the impact of geometric variations in the patient on 
the planned versus delivered dose on a day to day basis. The 
availability of daily volumetric MR images, in combination 
with software tools integrated into the MR-IGRT system, and 
independent quality assurance tools for online patient-
specific QA, has allowed for clinical use of online adaptive 
MR-IGRT since September 2014.  
We report on the first year of clinical experience with online 
treatment adaptation for over 45 patients treated to various 
sites including abdomen, pelvis, and thorax, having received 
more than a total of 150 adapted fractions. Here we describe 
the clinical implementation and workflow for online adaptive 
MR-IGRT, provide details on decision criteria for daily plan 
adaptation, and discuss and compare an online plan 
adaptation approach to a plan library approach where the 
plan of the day is selected from a group of plans based on 
previous patient anatomy. We also discuss limitations of 
current techniques and future improvements. 
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Purpose or Objective: The clinical target volume (CTV) in 
rectal cancer is subject to considerable shape deformations 
due to rectal and bladder filling changes, which require large 
planning target volume (PTV) margins when conventional 
correction strategies based on bony anatomy are used.  
To mitigate errors introduced by shape variations, the library 
of plans (LoP) approach has been successfully applied for 
cervical and bladder cancer. For those sites, libraries were 
created by interpolation of structures of interest defined on 
CT scans in the full and empty bladder state. However, for 
rectal patients this approach is not feasible, as a major 
source of uncertainty is not bladder, but rectal filling.  
The purpose of this study was therefore to develop an 
alternative method for generating structures for a LoP for 
rectal cancer and to investigate its potential for PTV margin 
reduction. 
 
Material and Methods: The method proposed is based on 3D 
population statistics of the shape variation of the rectum 
CTV, rather than patient specific data derived from several 
CT scans, allowing the use of only a single planning CT scan 
for structure generation. The population statistics were 
derived from shape variation data of thirty three short course 
radiotherapy (SCRT) patients with daily repeat scans on 
which the rectum CTV was delineated. Shape variations were 
defined as standard deviations of (local) perpendicular 
displacements of the CTV surface, using each patient’s 
planning CT scan as reference.  
The LoP CTVs were created by expanding or contracting the 
planning CTV perpendicular to its surface, proportional to the 
local statistics of shape variation of the population and a 
global scaling factor. The scaling factor was tuned such that 
the largest distance between CTVs was 1 cm. Five CTVs were 
created; the original CTV, two smaller (max -1, -2 cm) and 
two larger CTVs (max +1, +2 cm).  
To determine the potential of this method, residual errors 
were calculated by using the most optimal CTV from the 
library as a reference in computing the shape variation 
statistics, rather than the original planning CTV. 
Subsequently, margins were computed for both the 
conventional and LoP strategy, using a modified version of 
the van Herk recipe. 
 
Results: An example of the constructed CTV structures is 
depicted in figure 1a. The original CTV is the middle one; two 
larger and two smaller CTVs were created using population 
statistics. Figures 1c and 1d show the required PTV margin 
for a conventional and a LoP approach, respectively. The 
difference between the two methods is shown in Figure 1b. 
The largest reduction was found in the upper anterior part of 
the CTV: 1.5 cm (≈ 40%). 
 
Conclusion: We have successfully developed a LoP strategy 
for rectum patients that uses population statistics and 
scalable expansions, thereby only requiring a single CT scan, 
as opposed to the current methods for cervix and bladder. 
Analysis of the residual errors has shown that a potential 
margin reduction of 40% is possible with this approach. 
 
